Status:
UNKNOWN
Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth
Lead Sponsor:
University of Virginia
Collaborating Sponsors:
Johns Hopkins University
Virginia Commonwealth University
Conditions:
Decision Support Techniques
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prostate cancer is a commonly diagnosed cancer, and is the second leading cause of cancer deaths among men in the U.S. The subgroup of men with advanced prostate cancer is particularly vulnerable to d...
Detailed Description
Many patients with advanced prostate cancer along with their decision partners/ proxies (DPP) struggle with complex treatment decisions, such as when to start, change, or stop cancer directed treatmen...
Eligibility Criteria
Inclusion
- 1\) stages III/ IV prostate cancer 2) life expectancy ≥6 months 3) Karnofsky Performance Status \>60 4) willingness of a DPP (patient selected person who provides decisional support) to participate 5) pair ages \>18 years 6) ability to understand English
Exclusion
- severe psychiatric problems
Key Trial Info
Start Date :
July 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
316 Patients enrolled
Trial Details
Trial ID
NCT03327103
Start Date
July 21 2017
End Date
December 31 2021
Last Update
October 28 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21205
2
University of Virginia
Charlottesville, Virginia, United States, 22908
3
Virginia Commonwealth University
Richmond, Virginia, United States, 23219